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http://dx.doi.org/10.1016/j.numecd.2013.08.008Abstract Background and aims: Several smaller studies reported interactions between dietary
factors and apolipoprotein A5 (APOA5) gene polymorphisms in determination of plasma lipids.
We tested interactions between APOA5 haplotypes and dietary intake in determination of plasma
triglycerides (TG) and other lipids.
Methods and results: Participants (5487 males and females aged 45e69) were classiﬁed according
to the number (0, 1, 2þ) of minor APOA5 alleles (using T-1131 > C; rs662799 and Ser19 > Trp;
rs3135506 polymorphisms) and into three groups of low (bottom 25%), medium (26the75th
percentile) and high (top 25%) of intake of total energy and total, saturated and polyunsaturated
fats, assessed by food frequency questionnaire. The age-sex adjusted geometric means of plasma
TG increased with the number of minor alleles, from 1.57 (standard error 0.01), to 1.79 (0.02) to
2.29 (0.10) mmol/L (p < 0.00001) but TG did not differ between groups with low, medium and
high total energy intake (p Z 0.251). TG concentrations were highest in subjects with the com-
bination of 2þminor alleles and the highest energy intake (mean 2.59 [0.19], compared with 1.62
[0.03] in subjects with lowest energy intake and no minor allele) but the interaction between
energy intake and APOA5 haplotypes was not statistically signiﬁcant (p Z 0.186). Analogous an-
alyses with total, saturated and polyunsaturated fat intake yielded similar nonsigniﬁcant results.
Effects of APOA5 and dietary intakes on total and HDL cholesterol were weaker and no interac-
tions were signiﬁcant.
Conclusion: In this Slavic Caucasian population sample, we did not detect the hypothesized inter-
action between common SNPs within the APOA5 gene and diet in determination of blood lipids.
ª 2013 Elsevier B.V. All rights reserved.Introduction
Plasma levels of triglycerides (TG) are independent risk
factor of cardiovascular disease development [1]. Then A5; FFQ, food frequency
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mined. Probably the most important environmental factor
that may interact with genetic polymorphisms in deter-
mination of the plasma TG levels is diet. There is growing
interest in effect modiﬁcation between genes and envi-
ronment because such interactions could explain a num-
ber of discrepancies, such as differences in results between
association studies in different populations or inconsistent
effects of dietary interventions. However, the number of
studies addressing geneeenvironment interactions on
sufﬁcient number of individuals remains modest.
The most signiﬁcant impact on plasma TG levels seems
to be associated with apolipoprotein A5 gene (APOA5, gene
244 J.A. Hubacek et al.ID 116519, OMIM accession number 606368) variants [2,3].
ApoA5 is located on TG-rich and high density lipoprotein
(HDL) particles, enhances the activity of lipoprotein lipase
[4,5], and recombinant apoA5 binds to the LDL receptor
family members [6]. Minor alleles of two tagging APOA5
SNPs T-1131 > C [rs662799] and Ser19 > Trp [C56 > G,
rs3135506] were associated, although with different
strengths, with elevated plasma TG levels, regardless of
ethnicity and sex [3,7e10].
Several studies explored interactions of the effects of
APOA5 variants on different biochemical traits with dietary
factors. The results suggest that the APOA5 genotypes
modify the effects of dietary interventions (e.g. low/high
fat diet) [11e14], intake of fat [15,16] or alcohol intake [17]
on triglycerides (and less consistently on other lipids).
Since previous studies have been relatively small, used
different designs, selected patients and ethnically mixed
populations, the results remain inconclusive.
In this study, we have investigated the potential inter-
action of APOA5 with energy and fat intake in a large
sample of a general Slavonic Caucasian population. Our
working hypothesis was that plasma levels of TG are
highest in the combination of high energy/fat intake and
two or more minor alleles of APOA5 haplotypes (based on
the analysis of two polymorphisms (T-1131 > C and
Ser19 > Trp).Methods
Study population and study subjects
The study sample comes from the Czech part of the
HAPIEE (Health, Alcohol and Psychosocial factors In
Eastern Europe) project. The study examined random
samples of men and women aged 45e69 years in seven
Czech towns: Jihlava, Havirov, Hradec Kralove, Karvina,
Kromeriz, Liberec and Usti nad Labem. Details of the study
have been described elsewhere [18]. Brieﬂy, of the 8856
individuals recruited (response rate 55%), 6681 (3079
males and 3602 females) had DNA samples available. Of
these, 5847 people with non-missing data on all variables
of interest are included in the analyses reported here. The
subjects completed an extensive questionnaire on medical
history, health status, life style, diet and socioeconomic
and psychosocial factors, underwent a short examination,
including anthropometry, and provided a fasting blood
sample. The study was approved by the Local Ethics
Committees at both Czech National Institute of Public
Health and University College London, UK.Laboratory analyses
DNA was extracted using salting out method, and APOA5
SNPs rs662799 and rs3135506 were genotyped using PCR
e RFLP as described in details elsewhere [9]. Subjects were
classiﬁed according to the presence of minor APOA5 alleles
(C-1131 and Trp19) into three groups e 0, 1, 2 and more
minor alleles present.Plasma levels of TG, total cholesterol and HDL choles-
terol were analysed enzymatically using autoanalyzers and
conventional methods with reagents from Boehringer
Mannheim Diagnostics and Hoffmann-La Roche. The lab-
oratory (IKEM, Prague) is accredited by CDC, Atlanta.
Assessment of diet
Diet was assessed by a 143-item food frequency ques-
tionnaire (FFQ) with speciﬁed portion sizes adapted from
FFQ previously used in the US [19] and the UK [20]. The
intakes of total energy and fats (and other nutrients) were
estimated from the FFQ data using the McCance and
Widdowson’s The Composition of Foods [21], with correc-
tion for differences in the composition of principal foods
and adding composition of local foods and recipes [22]. For
the present analyses, subjects were classiﬁed into three
groups according to low (bottom 25%), medium
(25the75th percentile) and high (top 25%) intakes of total
energy and total, saturated and polyunsaturated fat (as
proportion of total energy); sex-speciﬁc cut-off points
were used to create these categories.
Statistical analysis
After excluding subjects with unreliable dietary data and
missing data for covariates, 5847 individuals with valid
APOA5 genotype were included in the analysis. The asso-
ciations of TG, total cholesterol and HDL cholesterol with
energy intake and APO5 haplotype was evaluate by linear
regression for males and females separately, controlling for
age. Interactions were assessed by adding interaction
terms to the linear regression models. Results are reported
as means and standard errors (SE); two-sided p-values are
also given. Since the distribution of TG was skewed, TG
values were logarithmically transformed. STATA statistical
software (version 12; College Station, TX) was used for all
statistical analyses.
Results
Descriptive characteristics of the individuals included in
the analysis are summarized in Table 1. The genotype
frequencies of both polymorphisms did not differ
signiﬁcantly from the previously described distributions
in Caucasian populations. In the entire study sample,
4322 (73.9%) subjects were carriers of the common al-
leles only; 1406 (24.0%) were carriers of one minor allele;
and 119 (2.0%) were carriers of at least two less common
alleles.
As expected, both variants had a signiﬁcant effect on
plasma TG levels (results not shown). When the two var-
iants were combined into one variable indicating the
number of minor alleles, the geometric means of TG
increased with the number of minor APOA5 alleles, from
1.57 (SE 0.01) mmo/L over 1.79 (0.02) mmo/L to 2.29
(0.10) mmo/L, p < 0.00001 (Table 2). Total cholesterol
(p < 0.001) increased linearly and HDL-cholesterol values
decreased (p < 0.001) with the number of minor APOA5
Table 1 Descriptive characteristics of the study sample.
Males Females All
N 2690 3157 5847
Age (years),
mean (SE)
58.0 (6.9) 57.2 (6.9) 57.6 (7.0)
TG (mmol/L),
mean (SE)
2.14 (1.65) 1.70 (0.96) 1.90 (1.34)
TC (mmol/L),
mean (SE)
5.61 (1.04) 5.84 (1.03) 5.73 (1.04)
HDL-C (mmol/L),
mean (SE)
1.25 (0.34) 1.51 (0.40) 1.39 (0.39)
BMI, (kg/m2),
mean (SE)




2096 (698) 1979 (709) 2033 (706)
Total fat (% of energy),
mean (SE)




13.1 (0.05) 13.0 (0.04) 13.1 (0.03)
Polyunsaturated
fats (% of energy),
mean (SE)
6.5 (0.03) 6.7 (0.03) 6.6 (0.02)
APOA5 minor alleles, n (%)
0 1999 (74.3) 2323 (73.6) 4322 (73.9)
1 636 (23.6) 770 (24.4) 1406 (24.1)
2 and more 55 (2.0) 64 (2.0) 119 (2.0)
Table 3 Mean concentrations (SE) of triglycerides and total and
HDL cholesterol (all in mmol/L) with the number of APOA5 minor
alleles by total energy intake category, adjusted for age and sex.
Energy intake Number of APOA5 minor alleles p for
trenda
0 1 2 And more
TG
<25% 1.62 (0.03) 1.78 (0.05) 2.19 (0.21) <0.001
>25e75% 1.56 (0.02) 1.78 (0.03) 2.19 (0.14) <0.001
>75% 1.55 (0.02) 1.80 (0.05) 2.52 (0.19) <0.001
p for interactionb Z 0.186
TC
<25% 5.76 (0.03) 5.70 (0.06) 6.02 (0.21) 0.843
>25e75% 5.68 (0.02) 5.81 (0.04) 5.92 (0.14) 0.003
>75% 5.71 (0.03) 5.84 (0.06) 6.12 (0.17) 0.004
p for interactionb Z 0.090
HDL
<25% 1.41(0.01) 1.36 (0.02) 1.34 (0.07) 0.033
>25%e75% 1.40(0.01) 1.36 (0.01) 1.35 (0.05) 0.003
>75% 1.41(0.01) 1.37 (0.02) 1.22 (0.06) 0.004
p for interactionb Z 0.401
a p-value for trend by the number of APOA5 minor alleles.
b p-values for differences in slope between 0 and 2 and more
minor alleles (interaction between energy intake and APOA5).
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with the number of the APOA5 minor alleles (Table 2).
Plasma TG levels did not differ signiﬁcantly between
groups with low, medium and high total energy intake;
the geometric means were 1.66 (0.02), 1.62 (0.02) and 1.63
(0.02), respectively, p for trend 0.251. There were no dif-
ferences in lipids by intakes of total fat, saturated fat or
polyunsaturated fat (not shown in table). The geometric
means of TG by the combination of energy intake category
and the number of minor alleles of APOA5 are shown in
Table 3. There is a suggestion that the combination of high
energy intake and 2 or more minor alleles produces the
highest TG levels (Fig. 1) but the interaction between totalTable 2 Means (standard errors) of lipid parameters (in mmol/L),
BMI (in kg/m2) and intake of energy (in kcal) and fat (as % of energy)
with APOA5 haplotype, adjusted for age and sex.
Number of the APOA5 minor alleles p
0 1 2 And
more
N 4322 1406 119
Triglyceridesa 1.57 (0.01) 1.79 (0.02) 2.29 (0.10) 0.00001
Total cholesterol 5.70 (0.07) 5.79 (0.03) 6.01 (0.09) 0.001
HDL-cholesterol 1.40 (0.01) 1.36 (0.01) 1.32 (0.03) 0.001
BMI 28.2 (0.07) 28.2 (0.12) 28.0 (0.41) 0.892
Energy intake 2036 (11) 2013 (19) 2083 (64) 0.545
Total fat 36.3 (0.1) 36.2 (0.2) 36.7 (0.6) 0.906
Saturated fats 13.1 (0.04) 13.0 (0.06) 13.2 (0.22) 0.499
Polyunsaturated
fats
6.6 (0.02) 6.6 (0.04) 6.7 (0.16) 0.350
a Geometric mean.energy intake and APOA5 haplotypes was not statistically
signiﬁcant (p Z 0.186).
Similarly, interactions between total energy intake and
APOA5 haplotype were not signiﬁcant in determination of
concentrations of total and HDL cholesterol (Table 3).
We also examined interactions with dietary intakes of
total fat, saturated fat or polyunsaturated fat. None of the
fat intake variables acted as effect modiﬁers of the asso-
ciation between APOA5 haplotypes and plasma lipids (all p
vales > 0.3, detailed results available on request). Finally,
there were no interactions between dietary intakes and
the individual APOA5 polymorphisms.
We conducted additional analyses using other meta-
bolic syndrome variables: systolic and diastolic blood
pressure and blood glucose. While all these variables were
associated with TG as expected (all p-values <0.001), noneFigure 1 Geometric means of TG by the combination of energy intake
and the number of APOA5 minor alleles.
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haplotype (all p-values >0.4), and stratiﬁcation for dietary
intake of energy or fat did not identify any association with
APOA5 in any subgroup (not shown in table).
Discussion
This study examined the potential interaction between
APOA5 haplotypes and dietary intake of energy and fats in
a large general Slavic Caucasian population sample in
relation to plasma lipids. We found that lipids were asso-
ciated with both individual polymorphisms in APOA5 and
with their combination but not with dietary intakes of
energy or saturated, unsaturated or polyunsaturated fats.
Although there was a suggestion that TG are highest in
carriers of at least two minor APOA5 alleles who also had
high energy intake, the interaction between APOA5
haplotype and any of the dietary indicators were not sta-
tistically signiﬁcant.
Limitations and strengths
The common/main problem of nutrigenetic studies is
insufﬁcient statistical power. The combination of small
sample size, heterogeneity of dietary assessments’ and
measurement inaccuracies reduce the ability of nutrige-
netic studies to reliably detect interactions between ge-
netic and dietary factors. Despite the large sample size,
only 2% of subjects in our study had 2 or more minor
APOA5 alleles; this would allow detection of only relatively
strong effect modiﬁcations. This may be one of the reasons
why none of the tested interactions in this study were
signiﬁcant.
Second, as mentioned above, most methods of dietary
assessment, including food frequency questionnaires, are
inaccurate. This misclassiﬁcation would further reduce the
ability of the study to detect main effects and interactions.
We have attempted to minimise this issue by comparing
groups with contrasting intakes (highest and bottom 25%)
but this may have not been sufﬁcient to completely over-
come the measurement bias.
Third, the subjects in this study were relatively old, and
the negative ﬁndings may not be generalised to younger
subjects with different life style than older persons.
However, the study also has several strengths. The
study was perhaps the largest so far published on the
potential APOA5-nutrition interaction and lipids. Second,
we have combined two tagging polymorphisms to create a
variable with a strong effect on plasma TG levels. Both
these aspects would increase the probability of detecting
an interaction with diet, if it exists. Finally, this study
examined a general population sample, unselected by
medical history, and the study population is ethnically
homogenous.
Interpretation
The need for the nutrigenetic analyses is widely
acknowledged by numerous authors [23e25]. However,studies with sufﬁcient numbers of well phenotypically
characterised individuals and sufﬁcient power remain
scarce. So far, there is some, but limited, evidence that
variants within the APOA5 gene may interact with envi-
ronmental, mainly dietary, factors.
Several experimental studies assessed whether changes
in blood lipids depended on the combination of diet and
APOA5 genotype. In a dietary trial in Korean patients with
hypertriglyceridemia, APOA5 T-1131T homozygotes
showed larger decrease in plasma TG after combined di-
etary and exercise intervention [11]. In a Chinese study, the
changes in TG after high carbohydrate/low fat diet interact
with APOA5-1131 TT genotype in women but not in men
[12]. Another Koran study of low/high fat diet suggested
that postprandial TG elevation differed by APOA5 T-1131T
genotype [13]. In the Pounds Lost trial, another APOA5
variant, rs964184, inﬂuences reduction in total and LDL
cholesterol in the low fat intake group [14].
In addition to experimental studies, there have also
been studies in general population samples. Among 117
Czech males whose dietary composition markedly
changed over an 8-year period, decrease in total choles-
terol (but not TG) was associated with the Ser19 > Trp
polymorphism [26,27]. Results from the Framingham
Heart study have shown that individuals consuming the
diet rich in polyunsaturated fatty acids had higher fasting
TG levels, if they carried at least one C-1131 allele; this
interaction was speciﬁc for the omega-6 fatty acids only
[15]. Interestingly, the second common APOA5 variant
(Ser19 > Trp) did not interact with high polyunsaturated
fat intake. In the Boston Puerto Rican Health Study, carriers
of the C-1131 allele had higher levels of TG and total
cholesterol if they also had high total fat intake [16]. By
contrast, no geneediet interaction was observed in as
study of 250 elderly Brazilian women in Ref. [28]. Finally, a
study of a Spanish population sample reported an inter-
action between APOA5-1131, fat intake and TG but the
lowest TG levels were found in the combination of minor
allele with high fat intake [29]. Among studies focused on
the same polymorphism as this investigation, all studies,
except Sanchez-Moreno et al., found highest TG levels in
subjects with the minor allele and high fat intake. This
general pattern is consistent with our ﬁndings, but in our
study, despite being several times larger than the others,
the interaction did not reach statistical signiﬁcance.
Overall, the non-signiﬁcant tendency of TG being
highest among subjects with the combination 2þ minor
alleles and the highest energy intake, together with
studies reported in the literature may be consistent with
the hypothesis that common SNPs within the APOA5 gene
interact with diet in determination of blood lipids. How-
ever, the interaction is likely to be weak and a conclusive
study would require a very large sample size to conﬁrm or
reject this hypothesis.
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